Structure | Chemical Name | CAS | MF |
|
VRT-1353385
|
1616113-45-1
|
C35H39NO11
|
|
Spiro[9H-fluorene-9,4'-piperidine]-1'-carboxylic acid, 2,7-dibromo-, 1,1-dimethylethyl ester
|
1616113-98-4
|
C22H23Br2NO2
|
|
1616114-00-1
|
1616114-00-1
|
C19H17Br2NO
|
|
(2,6-Dichlorophenyl)(Isopropyl)Sulfane
|
1616135-07-9
|
C9H10Cl2S
|
|
3',1'']terphenyl-5'-yl-[1,3,5]triazine
|
1616231-57-2
|
C27H18ClN3
|
|
N-[4-(4-dibenzofuranyl)phenyl]-2-aminobiphenyl
|
1616231-93-6
|
C30H21NO
|
|
2,4-Dichloro-6-[1,1':3',1''-terphenyl]-5'-yl-1,3,5-Triazine
|
1616232-09-7
|
C21H13Cl2N3
|
|
PF-06726304
|
1616287-82-1
|
C22H21Cl2N3O3
|
|
7-bromo-5,8-dichloro-3,4-dihydroisoquinolin-1(2H)-one
|
1616289-35-0
|
C9H6BrCl2NO
|
|
(2R,5S,13aR)-8-methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
1616340-94-3
|
C22H20F3N3O5
|
|
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid
|
1616342-45-0
|
C15H16N2O6
|
|
MonoMethyl FuMarate-d3
|
1616345-41-5
|
C5H3D3O4
|
|
6-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline hydrochloride
|
1616370-88-7
|
C11H16ClNO
|
|
Cyclopropyl(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)Methanone
|
1616388-38-5
|
C15H24BNO3
|
|
EPZ015666
|
1616391-65-1
|
C20H25N5O3
|
|
GSK591
|
1616391-87-7
|
C22H28N4O2
|
|
GSK-3326595
|
1616392-22-3
|
C24H32N6O3
|
|
9-[4-(4-bromophenyl)-6-phenyl-1,3,5-triazin-2-yl]-9H-Carbazole
|
1616413-67-2
|
C27H17BrN4
|
|
UCB9608
|
1616413-96-7
|
C20H26N8O2
|
|
4-(6-Amino-1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-methyl-piperazine-1-carboxylic acid tert-butyl ester
|
1616415-40-7
|
C17H27N7O2
|
|
CFI-400945 fumarate
|
1616420-30-4
|
C37H38N4O7
|
|
tert-butyl (3-amino-2,6-dichloropyridin-4-yl)carbamate
|
1616434-23-1
|
C10H13Cl2N3O2
|
|
N-[2-(Methacryloyloxy)ethyl]-N,N-dimethylbutan-1-aminium Bis(trifluoromethanesulfonyl)imide
|
1616483-28-3
|
C14H24F6N2O6S2
|
|
Tucidinostat (Chidamide)
|
1616493-44-7
|
C22H19FN4O2
|
|
2-(2-chloro-4-quinazolinyl)-9-phenyl-9H-Carbazole
|
1616499-37-6
|
C26H16ClN3
|
|
1,5-Difluoro-3-Methyl-2,4-dinitrobenzene
|
1616526-79-4
|
C7H4F2N2O4
|
|
1,5-Difluoro-3-Methyl-2-nitrobenzene
|
1616526-80-7
|
C7H5F2NO2
|
|
6-Chloro-3-Methoxy-2-nitropyridine
|
1616526-81-8
|
C6H5ClN2O3
|
|
5-HydroxypyriMidin-4(3H)-one hydrochloride
|
1616526-82-9
|
C4H5ClN2O2
|
|
IMidazo[1,5-a]pyridine-7-carboxylic acid dihydrochloride
|
1616526-83-0
|
C8H8Cl2N2O2
|
|
5-MethoxychroMan-4-ol
|
1616526-84-1
|
C10H12O3
|
|
5-Fluoro-1-Methyl-3-nitropyridin-2(1H)-one
|
1616526-85-2
|
C6H5FN2O3
|
|
Rivaroxaban iMpurity
|
1616563-62-2
|
C15H17N3O5
|
|
Erythrinin D
|
1616592-59-6
|
C21H18O6
|
|
Erythrinin F
|
1616592-60-9
|
C20H18O7
|
|
Erythrinin G
|
1616592-61-0
|
C20H18O6
|
|
3,8-Dihydroxy-1,9-dimethoxy-11H-benzofuro[2,3-b][1]benzopyran-11-one
|
1616592-62-1
|
C17H12O7
|
|
(3-Chloro-2-fluoro-4-methoxyphenyl)methanol
|
1616601-81-0
|
C8H8ClFO2
|
|
2-(2-BroMophenyl)-9H-phenylcarbazole
|
1616607-88-5
|
C24H16BrN
|
|
TIC10
|
1616632-77-9
|
C24H26N4O
|
|
1,3-Di(pyren-1-yl)benzene
|
1616657-81-8
|
C38H22
|
|
Tetrazine-NHS Ester
|
1616668-55-3
|
C14H11N5O4
|
|
Dodovisone A
|
1616683-50-1
|
C27H30O8
|
|
Dodovisone B
|
1616683-51-2
|
C27H32O9
|
|
Dodovislactone B
|
1616683-55-6
|
C21H30O5
|
|
1,1-bis(pyridin-2-ylmethyl)-2,2-bisimidazole
|
1616685-69-8
|
C18H16N6
|
|
Desidustat
|
1616690-16-4
|
C16H16N2O6
|
|
2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
|
1616703-93-5
|
C25H30F2N6O5S
|
|
Ivabradine IMpurity
|
1616710-50-9
|
C27H35ClN2O6
|
|
1616710-52-1
|
1616710-52-1
|
C27H34N2O6
|
|
Caesalpine A
|
1616757-59-5
|
C23H32O7
|
|
Caesalpine B
|
1616757-60-8
|
C23H30O7
|
|
Tofacitinib Impurity 2
|
1616760-97-4
|
C13H18ClN5
|
|
3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
|
1616761-00-2
|
C16H19ClN6O
|
|
methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate
|
1616761-01-3
|
C17H23N5O3
|
|
2-Pyrimidinemethanamine, α-methyl-, hydrochloride (1:1)
|
1616809-52-9
|
C6H9N3.ClH
|
|
2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine
|
1616841-66-7
|
C29H18BrN3
|
|
Formoterol EP Impurity E
|
1616967-26-0
|
C20H26N2O4
|
|
RA190
|
1617495-03-0
|
C28H23Cl5N2O2
|
|
Bis[1-(9,9-dimethyl-9H-fluoren-2-yl)-isoquinoline](acetylacetonate)iridium(III)
|
1617506-77-0
|
C53H43IrN2O2
|
|
Methyl 3-aMino-4-(aMinoMethyl)benzoate
|
1618083-32-1
|
C9H12N2O2
|
|
2-chloro-4-(dibenzo[b,d]furan-2-yl)-6-phenyl-1,3,5-triazine
|
1618107-00-8
|
C21H12ClN3O
|
|
Prasugrel Impurity 4 HCl
|
1618107-96-2
|
C20H22Cl2FNO3S
|
|
IZCHRAOWOKMDHU-UHFFFAOYSA-N
|
1618107-98-4
|
C18H18FNO2S
|
|
Prasugrel Impurity 13 HCl
|
1618108-01-2
|
C18H19ClFNOS
|
|
Ozanimod hydrochloride
|
1618636-37-5
|
C23H25ClN4O3
|
|
Alogliptin Related Compound 23
|
1618644-29-3
|
C20H13ClN4O2
|
|
Alogliptin benzoate impurity K
|
1618644-32-8
|
C25H25N5O3
|
|
CC-671
|
1618658-88-0
|
C28H28N6O4
|
|
1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene
|
1618672-71-1
|
C22H12Cl4N2O4
|
|
4'-(1,2,2-Triphenylethenyl)[1,1'-biphenyl]-4-ol
|
1618678-20-8
|
C32H24O
|
|
Methyl 2-aMino-6-chlorobenzoate hydrochloride
|
1619264-45-7
|
C8H9Cl2NO2
|
|
(1-(Pyridin-3-yl)piperidin-4-yl)Methanol
|
1619264-47-9
|
C11H16N2O
|
|
2-BroMooxazole-5-carboxylic acid hydrate
|
1619264-49-1
|
C4H4BrNO4
|
|
4-(2-(2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoroMethyl)benzonitrile
|
1619264-51-5
|
C14H12F6N2O
|
|
(2S)-1-(11bS)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphe
pin-4-yl-1,2,3,4-tetrahydro-2-methylquinoline,99%e.e.
|
1619901-87-9
|
C30H24NO2P
|
|
LY2857785
|
1619903-54-6
|
C26H36N6O
|
|
9-[1,1'-Biphenyl]-3-yl-9'-phenyl-3,3'-bi-9H-carbazole
|
1619966-75-4
|
C42H28N2
|
|
5,5'-dibromo-3,3'-difluoro-2,2'-bithiophene
|
1619967-08-6
|
C8H2Br2F2S2
|
|
(3,3'-Difluoro-[2,2'-bithiophene]-5,5'-diyl)bis(trimethylstannane)
|
1619967-09-7
|
C14H20F2S2Sn2
|
|
N-(indan-2-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine
|
1619971-57-1
|
C16H18N4
|
|
(2,4-DIFLUORO-3-METHYLPHENYL)BORONIC ACID
|
1619980-13-0
|
C7H7BF2O2
|
|
GSK 2801
|
1619994-68-1
|
C20H21NO4S
|
|
BroMosporine
|
1619994-69-2
|
C17H20N6O4S
|
|
5-Chlorosaligenyl-N,N-diisopropylphosphoramidite
|
1620086-77-2
|
C13H19ClNO2P
|
|
(R)-1-benzyl-5-methyl-1,4-diazepane
|
1620097-06-4
|
C13H20N2
|
|
Suvorexant
intermediate
|
1620097-07-5
|
C23H27N5O
|
|
Methyl cis-1-Boc-4-aMinopiperidine-3-carboxylate
|
1620128-54-2
|
C12H22N2O4
|
|
(S)-5-bromo-2-(2-(trifluoromethyl)pyrrolidin-1-yl)pyrimidine
|
1620136-60-8
|
C9H9BrF3N3
|
|
(S)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2-(trifluoromethyl)pyrrolidin-1-yl)pyrimidine
|
1620136-61-9
|
C15H21BF3N3O2
|
|
(S)-6-(2-(2-(trifluoromethyl)pyrrolidin-1-yl)pyrimidin-5-yl)pyridine-2-amine
|
1620136-62-0
|
C14H14F3N5
|
|
(S)-5-(6-chloropyrazin-2-yl)-2-(2-(trifluoromethyl)pyrrolidin-1-yl)pyrimidine
|
1620136-70-0
|
C13H13F3N6
|
|
Acrylo POSS Cage Mixture
|
1620202-27-8
|
|
|
2-Chloro-4-(BOC-amino)phenylboronic acid, pinacol ester
|
1620228-06-9
|
C17H25BClNO4
|
|
Sitagliptin D4 Hydrochloride
|
1620233-72-8
|
C16H15F6N5O
|
|
1-(4-(Aminomethyl)benzyl)-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine dihydrochloride
|
1620278-72-9
|
C22H26ClN5
|
|
4-((2,4-difluoro-5-((2R,3S)-3-(5-fluoropyrimidin-4-yl)-2-hydroxy-1-(1H-1,2,4-triazol-1-yl)butan-2-yl)phenyl)amino)-4-oxobutanoic acid
|
1620283-05-7
|
C20H19F3N6O4
|
|
(R)-3,3'-Bis[[[(1R,2R)-2-(isoindolin-2-yl)-1,2-diphenylethyl]imino]methyl]-1,1'-bi-2-naphthol
|
1620285-48-4
|
C66H54N4O2
|
|
2-THIOPHENEACETIC ACID, 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-, ETHYL ESTER
|
1620318-41-3
|
C14H21BO4S
|
|
3-(5-Amino-3-methyl-1H-pyrazol-1-yl)benzoic acid hydrochloride
|
1620390-43-3
|
C11H12ClN3O2
|